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Research
Numerous epidemiological studies have dem-
onstrated a consistent link between particulate 
matter (PM) air pollution, especially fine PM 
[aerodynamic diameter ≤ 2.5 μm (PM2.5)], and 
increased cardiopulmonary morbidity and mor-
tality (Brook et al. 2004; Mann et al. 2002; 
Pope et al. 2002; Samet et al. 2009; Schwartz 
1999). Previous studies have suggested that 
PM2.5 exposure is significantly associated with 
increased heart rate and decreased heart rate 
variability (HRV; Gold et al., 2000; He et al. 
2010; Liao et al. 1999; Luttmann-Gibson et al. 
2006; Magari et al. 2001; Park et al. 2005). 
Increased heart rate and impaired HRV are 
indicative of autonomic nervous system dys-
function in the direction of increased sympa-
thetic outflow and weakened parasympathetic 
modulation. Such an impaired autonomic 
modulation may decrease the threshold of 
arrhythmia and trigger the onset of premature 
ventricular contractions (PVCs) and prema-
ture atrial contractions (PACs) (Huikuri et al. 
2001), the most common forms of arrhyth-
mia in the general population (Engel et al. 
2007; Rautaharju et al. 2006). It is therefore 
biologically plausible that higher exposures to 
PM2.5 may increase the risk of common forms 
of arrhythmia. Most of the previous studies 
relating air pollution exposure and arrhythmia 
were carried out in patients with implantable 
cardioverter defibrillators (ICDs; Dockery et al. 
2005; Peters et al. 2000; Vedal et al. 2004). 
Patients with ICDs often have severe under-
lying structural cardiovascular conditions. 
Thus, the results from such patient-based data 
may not reflect the effect of PM2.5 exposure 
on arrhythmia in the general population, espe-
cially among healthy persons. Recently, Liao 
et al. (2009) reported that elevated geographic 
information systems–estimated ambient PM2.5 
exposures 1 day before the electrocardiogra-
phy (ECG) measurement were associated with 
increased odds of PVC in women enrolled in 
the Women’s Health Initiative (WHI) clinical 
trials study. However, very little is known about 
arrhythmic effects of individual-level PM2.5 
exposures or the time course of PM2.5 effects.
We designed this study to investigate the 
effects and the time course, that is, the time 
period from exposure to cardiac response, of 
individual-level PM2.5 exposures on the risk of 
PVC and PAC from 24-hr beat-to-beat Holter 
ECG recordings in a middle-age community-
dwelling sample of healthy nonsmokers.
Materials and Methods
Population. For this report, we used the data 
collected for the Air Pollution and Cardiac Risk 
and Its Time Course (APACR) study, which 
we designed to investigate the mechanisms 
and time course of the adverse effects of PM2.5 
on cardiac electrophysiology, blood coagula-
tion, and systemic inflammation. Recruitment 
methods and examination procedures for the 
APACR study have been published elsewhere 
(He et al. 2010; Liao et al. 2010). Briefly, all 
study participants were recruited from com-
munities in central Pennsylvania, primarily 
from the Harrisburg metropolitan area. The 
inclusion criteria for the study included non-
smoking adults ≥ 45 years old who had not 
been diagnosed with severe cardiac problems 
(defined as diagnosed valvular heart disease, 
congenital heart disease, acute myocardial 
infarction or stroke within 6 months, or con-
gestive heart failure). Approximately 75% of 
the individuals who were contacted and who 
met our inclusion criteria were enrolled in the 
APACR study. Our targeted sample size was 
100 individuals, and we enrolled and examined 
106 individuals for the APACR study. One 
participant was excluded because of extremely 
high-frequency and complex PVCs. PM2.5 and 
Holter ECG monitoring was initiated between 
0800 and 1000 hours on day 1, immediately 
after participants were administered a standard-
ized questionnaire and underwent a brief phys-
ical examination and a fasting blood draw by a 
trained and certified research nurse. The next 
morning, the participants returned to remove 
the monitors and had their second blood draw. 
The APACR study has maintained approval by 
the Pennslyvania State University College of 
Medicine institutional review board. All par-
ticipants gave written informed consent before 
their participation in the study.
Personal PM2.5 exposures. The APACR 
study used a personal PM2.5 DataRam (pDR, 
model 1200; Thermo Scientific, Boston, MA) 
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Ba c k g r o u n d: The mechanisms underlying the relationship between particulate matter (PM) air 
pollution and cardiac disease are not fully understood.
oBjectives: We examined the effects and time course of exposure to fine PM [aerodynamic diam-
eter ≤ 2.5 μm (PM2.5)] on cardiac arrhythmia in 105 middle-age community-dwelling healthy non-
smokers in central Pennsylvania.
Me t h o d s : The 24-hr beat-to-beat electrocardiography data were obtained using a high-resolution 
Holter system. After visually identifying and removing artifacts, we summarized the total number 
of premature ventricular contractions (PVCs) and premature atrial contractions (PACs) for each 
30-min segment. A personal PM2.5 nephelometer was used to measure individual-level real-time 
PM2.5 exposures for 24 hr. We averaged these data to obtain 30-min average time–specific PM2.5 
exposures. Distributed lag models under the framework of negative binomial regression and gener-
alized estimating equations were used to estimate the rate ratio between 10-μg/m3 increases in aver-
age PM2.5 over 30-min intervals and ectopy counts.
re s u l t s: The mean ± SD age of participants was 56 ± 8 years, with 40% male and 73% non-
Hispanic white. The 30-min mean ± SD for PM2.5 exposure was 13 ± 22 μg/m3, and PAC and PVC 
counts were 0.92 ± 4.94 and 1.22 ± 7.18. Increases of 10 μg/m3 in average PM2.5 concentrations 
during the same 30 min or the previous 30 min were associated with 8% and 3% increases in aver-
age PVC counts, respectively. PM2.5 was not significantly associated with PAC count.
co n c l u s i o n: PM2.5 exposure within approximately 60 min was associated with increased PVC 
counts in healthy individuals.
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for real-time 24-hr personal PM2.5 exposure 
assessment. Details of the exposure assess-
ment (He et al. 2010; Liao et al. 2010) and 
of the instrument’s performance have been 
reported elsewhere (Rea et al. 2001; Reed 
et al. 2000; Wallace et al. 2005; Williams 
et al. 2009). Real-time PM2.5 concentrations 
were recorded at 1-min intervals and averaged 
over 30-min segments, beginning on the hour 
or half-hour. Therefore, the PM2.5 exposure 
variables were treated as repeated measures, 
and each individual contributed 48 exposure 
data points over 24 hr.
Continuous ambulatory ECG and arrhyth-
mia. A high-fidelity (sampling frequency, 
1,000 Hz) 12-lead HScribe Holter System 
(Mortara Instrument, Inc., Milwaukee, WI) 
was used to collect the 24-hr Holter beat-to-
beat ECG data. The details of the Holter ECG 
data collection and reading have been pub-
lished elsewhere (He et al. 2010; Liao et al. 
2010). Relevant to this report, the Holter 
ECG data were scanned to a designated com-
puter for offline processing by an experienced 
investigator using HScribe System software 
(version 4.21; Mortara Instrument, Inc.). The 
main objective of the offline processing was 
to verify the Holter-identified ECG waves 
and to identify and label additional elec-
tronic artifacts and arrhythmic beats in the 
ECG recording. An experienced ECG reader 
visually reviewed and verified all arrhythmic 
beats in the ECG recording. For each par-
ticipant, we calculated the 30-min segment-
specific PVC and PAC counts and summed 
the PVC and PAC counts to determine the 
total ectopic beats. The counts were treated 
as repeated measures, and each individual 
contributed 48 data points for each of the 
three arrhythmic beat counts to the analysis. 
We performed time- and frequency-domain 
HRV analysis on the artifact-free and ecto-
py-free normal R-to-R intervals on each of 
the 30-min–based ECG segments, accord-
ing to current recommended practice (Task 
Force of the European Society of Cardiology 
1996). The following HRV indices were used 
as indices of cardiac autonomic modulation: 
standard deviation of all R-to-R intervals 
(SDNN; milliseconds), square root of the 
mean of the sum of the squares of differences 
between adjacent R-to-R intervals (RMSSD; 
milliseconds), power in the low-frequency 
(LF; 0.04–0.15 Hz) and high-frequency (HF; 
0.15–0.40 Hz) range, and the ratio of LF 
and HF.
Other individual-level covariables. A stan-
dardized questionnaire developed by APACR 
investigators was used to collect the following 
individual-level information: demographic 
variables, including age, race, sex, and high-
est education level; medication uses, includ-
ing antianginal medication, antihypertensive 
medication, and antidiabetic medication; and 
physician-diagnosed chronic disease history, 
including cardiovascular disease (CVD; revas-
cularization procedures and myocardial infarc-
tion), hypertension, and diabetes. The averages 
of the second and third measures of seated sys-
tolic and diastolic blood pressures on day 1 were 
used to represent a participant’s blood pressure 
levels. Day 1 fasting glucose was measured by 
the Pennsylvania State University College of 
Medicine General Clinical Research Center’s 
central laboratory (Hershey, PA). CVD was 
defined by antianginal medication use or a his-
tory of CVD. Hypertension was defined by 
antihypertensive medication use, physician-
  diagnosed hypertension, systolic blood pres-
sure ≥ 140 mmHg, or diastolic blood pressure 
≥ 90 mmHg. Diabetes was defined by anti-
diabetic medication use, physician-  diagnosed 
diabetes, or fasting glucose > 126 mg/dL. Body 
mass index (BMI) was defined as the ratio of 
weight to height squared.
Weather variables. We obtained real-
time temperature and relative humidity 
using a HOBO H8 logger (Onset Computer 
Corporation, Bourne, MA) directly fixed on 
top of the container housing the PM2.5 moni-
tor. The real-time temperature and relative 
humidity were recorded at 1-min intervals 
and averaged over 30-min segments corre-
sponding to the time segments during which 
PM2.5 and arrhythmias were measured. The 
weather variables were treated as repeated 
measures, and each individual contributed 48 
data points for each.
Statistical analysis. Two-sample t-tests, 
Wilcoxon-Mann-Whitney tests, chi-square 
tests, or Fisher’s exact tests, as appropriate, 
were used to compare the distributions of basic 
demographic variables between participants 
with and without chronic diseases. We used 
distributed lag models (Almon 1965; Pope 
and Schwartz 1996; Schwartz 2000) under the 
framework of a negative binomial regression 
model (Hilbe 2007) and generalized estimat-
ing equations (Hardin and Hilbe 2003) to 
assess the regression coefficients measuring the 
association between 30-min PM2.5 and each 
of the arrhythmic beat counts. Negative bino-
mial regression can be viewed as an extension 
of Poisson regression, and, as for Poisson regres-
sion, the exponentiated regression coefficients 
represent rate ratios (RRs). However, unlike 
Poisson regression, negative binomial regression 
does not require the strong, and often violated, 
Table 1. Demographic characteristics of the study population.a
All subjects 
(n = 105)
Hypertension, diabetes, or CVD
Characteristic No (n = 60) Yes (n = 45) p-Valueb
Age 56 ± 7.6 56 ± 8.2 57 ± 6.8 0.32
Sex (% male) 40 40 40 1.00
Race/ethnicity (% non-Hispanic white) 73 72 76 0.66
Glucose (mg/dL) 89 ± 25 85 ± 10 94 ± 36 0.10
BMI (kg/m2) 28 ± 5.9 26 ± 4.3 30 ± 7.1 < 0.01
CVD (%) 7.6 0.00 18 < 0.01
Hypertension (%) 35 0.00 85 < 0.01
Diabetes (%) 7.6 0.00 18 < 0.01
Blood pressure (mmHg)
Systolic 122 ± 16 117 ± 12 128 ± 18 < 0.01
Diastolic 75 ± 9.2 73 ± 8.3 77 ± 9.8 0.02
Education, college or higher (%) 79 73 87 0.10
Medicine use (%)
Hypertension 19 0.00 44 < 0.01
Diabetes 6.7 0.00 16 < 0.01
Arrhythmia 1.9 0.00 4.4 0.18
HRV indices
Log HF (msec2) 6.70 ± 1.02 6.80 ± 1.01 6.56 ± 1.03 < 0.01
Log LF (msec2) 6.29 ± 0.96 6.41 ± 0.94 6.12 ± 0.96 < 0.01
SDNN (msec) 66.60 ± 31.32 69.37 ± 31.06 62.93 ± 31.29 < 0.01
RMSSD (msec) 25.76 ± 17.81 26.86 ± 17.98 24.30 ± 17.48 < 0.01
Ectopy variables
PVC count 1.22 ± 7.18 0.91 ± 3.74 1.63 ± 10.05 < 0.01
PAC count 0.92 ± 4.94 0.66 ± 2.42 1.26 ± 6.99 < 0.01
Total ectopy count 2.14 ± 8.91 1.58 ± 4.51 2.90 ± 12.54 < 0.01
Lag 0 measures
PM2.5 (μg/m3) 13.49 ± 21.60 11.88 ± 14.77 15.62 ± 28.06 < 0.01
Temperature (°C) 21.75 ± 3.54 21.84 ± 3.66 21.64 ± 3.38 0.05
Relative humidity (%) 39.65 ± 12.11 40.19 ± 12.32 38.93 ± 11.78 < 0.01
IQRc of PM2.5 (μg/m3)
Lag 0 6.38 7.08 5.60 0.60
Lag 0–1 6.57 6.80 5.43 0.80
Lag 0–2 5.97 6.57 5.37 0.85
Lag 0–3 5.83 6.55 5.07 0.75
Lag 0–4 6.06 6.35 4.95 0.63
aResults are presented as mean ± SD for continuous variables and percentages for categorical variables. bp-Value for 
comparing CVD and no-CVD groups. cThe median of the within-individual IQRs of PM2.5 concentration.PM2.5 affects cardiac arrhythmia
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assumption that the variability of counts with 
a particular covariate pattern is equal to the 
mean. We specified a first-order autoregres-
sive correlation structure to adjust for within-
individual autocorrelation. In these models, one 
lag indicates a 30-min separation between the 
exposure and outcome. Thus, lag 0 indicates 
that the PM2.5 data were collected and averaged 
over the same 30-min segment as the ectopic 
beat count data, lag 1 indicates that the PM2.5 
data were collected during the previous 30 min, 
lag 2 indicates that the PM2.5 data were col-
lected during the 30-min segment 30–60 min 
before the ectopic beats were counted, and so 
forth. We chose a constrained distributed lag 
model, the polynomial distributed lag model, 
to reduce the potential collinearity of PM2.5 
between individual lags using a second-degree 
polynomial. Because high levels of collinear-
ity may exist for PM2.5 measurements taken 
closely together in time, the lag weights in the 
distributed lag model can be constrained to 
reduce collinearity by imposing a shape on 
the lag distribution, with a common approach 
being to constrain the lag weights to follow 
a low-order polynomial function. Thus, the 
model is termed a polynomial distributed lag 
model. Another advantage of the distributed 
lag model is its ability to provide interpretation 
of the cumulative effects of the lags included 
in the model, as well as individual lag effects. 
Cumulative effects are modeled by including 
all lags to be accumulated in a single model, 
and obtaining an estimate of the weighted 
average of the lag effects. Because PM2.5 expo-
sures and ectopic beats were assessed in parallel 
over 48 lags (24 hr), we decided a priori to 
model no more than 10 lags, which allowed 
us to fit the distributed lag models using at 
least 80% of the data. Using PVC count per 
30 min as the primary outcome variable, we 
started from the largest number of lags (lag 
0–10) and reduced the total number of indi-
vidual lags by back-eliminating the longer lags 
(e.g., lag 10), one lag at a time, until a sig-
nificant cumulative effect from all the included 
lags (< 0.05) was identified (lag 0–1 for PVC 
in this article). We then used this model as our 
final model for all arrhythmia count variables. 
In addition to distributed lag models, we fitted 
moving average models that implicitly assume 
equal weighting of the lag effects, in contrast 
with the distributed lag model that allows the 
weighting to differ among the lags. We tested 
effect modification by sex and chronic disease 
status (hypertension, diabetes, or history of 
CVD) in the final model. The RR [95% con-
fidence interval (CI)] for the PM2.5 and ectopy 
relationship at each level of the effect modi-
fier was reported if there was significant effect 
modification (< 0.05). All results are expressed 
per 10-μg/m3 increase in PM2.5. We used SAS 
statistical software (version 9; SAS Institute 
Inc., Cary, NC) for all analyses.
Results
Table 1 presents demographic and clinical 
characteristics and the ectopy counts in this 
community-based sample of 105 middle-age 
healthy nonsmokers. The mean age of the 
participants was 56 years, with 73% non-
Hispanic white, 60% females, and 43% 
classi  fied as having chronic disease (CVD, 
hyper  tension, or diabetes). The prevalence of 
CVD, hypertension, and diabetes was 7.6%, 
35.2%, and 7.6%, respectively. At the popu-
lation level, the 30-min mean ± SD PAC and 
PVC counts were 0.92 ± 4.94 and 1.22 ± 
7.18, respectively. Participants classified as 
having chronic disease had significantly higher 
average PAC and PVC counts and signifi-
cantly lower HRV indices (HF, LF, SDNN, 
and RMSSD) than did other participants 
(< 0.01 for all outcomes). The average (± SD) 
exposure to PM2.5 (over all 30-min seg-
ments) was 13.49 ± 22 μg/m3. The medians 
of the within-individual interquartile ranges 
(IQR) for the entire study sample on lag 0, 
lag 0–1, lag 0–2, lag 0–3, and lag 0–4 PM2.5 
concentration were 6.38 μg/m3, 6.57 μg/m3, 
5.97 μg/m3, 5.83 μg/m3, and 6.06 μg/m3, 
respectively, which indicates no substantial 
variation in the IQRs across the window of 
exposure. Therefore, we modeled the rela-
tionship between PM2.5 and ectopy risk per 
10-μg/m3 increase of PM2.5 across all models. 
Figures 1 and 2 show the 30-min segment-
specific distributions of the mean + SD of the 
PM2.5 levels and total ectopy counts (PVC 
and PAC counts combined) across the entire 
study population.
According to the model selection strategy 
described above, the final model for all out-
comes contained only two lags: lag 0 (expo-
sure and outcome measured during the same 
30-min segment) and lag 1 (exposure mea-
sured during the previous 30 min). Table 2 
presents the multivariable-adjusted RR (95% 
CI) for associations between PM2.5 (expressed 
in 10-μg/m3 increments) and PVC, PAC, and 
total ectopy counts. Associations of PM2.5 with 
PVC and total ectopy counts were statistically 
significant for lag 0 and lag 0–1 models. For 
example, the RR (95% CI) of PVC associated 
with a 10-μg/m3 increase in PM2.5 during lag 
0 and lag 0–1 was 1.08 (1.05–1.10) and 1.03 
(1.00–1.05), respectively, indicating an 8% 
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and 3% increase in PVC counts, respectively. 
In contrast, PM2.5 was not positively asso-
ciated with PAC count. The RRs (95% CI) 
from moving average exposure models (data 
not shown) are comparable to those from 
distributed lag models in Table 2. For com-
parison purpose, we also present in Table 3 
estimated RRs (95% CI) from individual lags 
and cumulative RRs (95% CI) of PVC, PAC, 
and total ectopy counts from models that 
included all possible lags of PM2.5 exposures 
(lags 0–10). The individual lag RRs presented 
in Table 3 are consistent with the final models 
in Table 2: the very close individual lags (lag 0 
and lag 1), but not the longer lag terms (lag 2 
to lag 10), are significantly associated with 
higher RR of PVC and total ectopy counts, 
although some longer lag terms (lag 9 and 
lag 10) showed similar direction of their point 
estimates; and PM2.5 is not associated with 
PAC counts in these data.
To examine the influence of cardiac 
autonomic modulation on the relationship 
between PM2.5 exposure and PVC count, 
we modeled PM2.5 lag 0 and PVC adjust-
ing for HRV variables one at a time, in addi-
tion to the covariates as presented in Table 4. 
In summary, the association between PM2.5 
and PVC was reduced from an estimated 
8% increase in PVC count with a 10-μg/m3 
increase in exposure to a 3–7% increase after 
adjustment for HRV indices. We observed 
the largest difference with adjustment for 
RMSSD (RR = 1.03; 95% CI, 1.0–1.05), a 
marker of parasympathetic modulation.
Associations between PM2.5 on PVC and 
total ectopy counts were significantly stronger 
in participants without CVD-related comor-
bidity than in participants classified as having 
chronic disease (values for both interactions 
< 0.05; Table 5). Interactions were not sig-
nificant between chronic disease and PM2.5 
when PAC was the outcome, or between sex 
and PM2.5 for any of the outcomes at the 
≤ 0.05 level.
Discussion
The mechanisms responsible for the consis-
tently reported association between fine PM 
exposure and CVD mortality and morbidity 
are not fully understood. Previous studies have 
suggested several possible underlying mecha-
nisms, including cardiac autonomic impair-
ment as measured by lower HRV (Creason 
et al. 2001; Gold et al. 2000; He et al. 2010; 
Liao et al. 1999, 2004; Pope et al. 1999) and 
effects on ventricular repolarization (Campen 
et al. 2006; Ghelfi et al. 2008; Henneberger 
et al. 2005; Liao et al. 2010; Lux and Pope 
2009; Samet et al. 2009; Yue et al. 2007). 
Various studies, including patient-based popu-
lation studies, panel studies, large population-
based cohort studies, and controlled exposure 
studies, have indirectly suggested short-term 
PM effects on cardiac electrophysiology and 
outcomes (including HRV) (Elder et al. 2007; 
Liao et al. 1999, 2004; Park et al. 2005), ven-
tricular repolarization (Lux and Pope 2009; 
Yue et al. 2007), T-wave alternans (Zanobetti 
et al. 2009), myocardium ischemia (Zhang 
et al. 2009), and arrhythmias (Berger et al. 
2006; Dockery et al. 2005; Ebelt et al. 2005; 
Liao et al. 2009; Sarnat et al. 2006). The time 
course from PM exposure to effects on cardiac 
arrhythmia has not been investigated system-
atically in a middle-age community-dwelling 
sample of healthy nonsmokers. Cavallari et al. 
(2008) reported early- and later-phase HRV 
responses at 2 hr and 9–13 hr after expo-
sure, respectively. Rich et al. (2005, 2006a, 
2006b) also reported evidence of acute effects 
(1 hr) and longer cumulative effects (24-hr 
moving average) of elevated PM and gaseous 
concentrations on severe arrhythmias in ICD 
patients. We reported evidence of PM2.5 effects 
on HRV approximately 4–6 hr after expo-
sure (He et al. 2010) and of PM2.5 effects on 
ventricular repolarization 3–4 hr after expo-
sure (Liao et al. 2010). In the present study of 
105   community-dwelling healthy nonsmokers, 
exposure to PM2.5 was associated with PVC, 
but not with PAC, consistent with our findings 
in the WHI population (Liao et al. 2009) and 
with findings reported by Sarnat et al. (2006) 
from a panel study of older adults.
More important, our data suggest that 
exposures to PM2.5 are associated with increased 
PVC frequency, with an approximately 8% 
increase in the number of PVCs per 30 min for 
each 10-μg/m3 increase in PM2.5 concentra-
tion during the same time period (p < 0.01). 
The association was reduced to approximately 
3% for each 10-μg/m3 increase in PM2.5 con-
centration averaged over the same time period 
and the previous 30 min (p < 0.05). The asso-
ciation decreases progressively to the null when 
exposure is averaged over longer time periods, 
which suggests that the effect of PM2.5 expo-
sure on the presence and frequency of PVC 
within a 24-hr time period lasts for approxi-
mately 60 min. Previous studies of the time 
course of PM effects on arrhythmia suggested 
effects within days of exposure (Liao et al. 
2009; Peters et al. 2000), but these studies 
were based on daily-average exposures before 
ECG, in contrast with the present study. To 
our knowledge, this is the first study designed 
to have sufficient temporal resolution of both 
exposure and ECG variables, for example, on  Table 3. RRsa (95% CIs) of ectopy counts associated with a 10-μg/m3 increment of PM2.5 concentration 
from individual lags.
Lag PVC PAC Total ectopy
Lag 0 1.02 (1.00–1.04) 1.00 (0.97–1.01) 1.02 (1.00–1.03)
Lag 1 1.00 (1.00–1.01) 0.99 (0.97–1.01) 1.00 (1.00–1.01)
Lag 2 0.99 (0.98–1.00) 0.98 (0.96–1.01) 0.99 (0.98–1.00)
Lag 3 0.98 (0.96–1.00) 0.98 (0.96–1.00) 0.98 (0.97–1.00)
Lag 4 0.98 (0.95–1.00) 0.98 (0.96–1.00) 0.98 (0.96–1.00)
Lag 5 0.98 (0.95–1.00) 0.98 (0.96–1.00) 0.98 (0.95–1.00)
Lag 6 0.98 (0.95–1.01) 0.98 (0.97–1.00) 0.98 (0.96–1.00)
Lag 7 0.99 (0.96–1.02) 0.99 (0.97–1.01) 0.98 (0.96–1.01)
Lag 8 1.00 (0.97–1.03) 0.99 (0.98–1.01) 0.99 (0.97–1.01)
Lag 9 1.02 (0.98–1.06) 1.00 (0.98–1.03) 1.00 (0.99–1.03)
Lag 10 1.04 (0.98–1.10) 1.01 (0.98–1.05) 1.02 (0.99–1.06)
Cumulative 0.98 (0.79–1.21) 0.90 (0.74–1.09) 0.93 (0.80–1.09)
aThe RRs were calculated by exponentiating the regression coefficients from distributed lag negative binomial regression 
model, adjusted for age, sex, race, chronic disease status, and the same lag period temperature and relative humidity.
Table 4. HRV-adjusted RRsa (95% CIs) of PVC 
counts associated with a 10-µg/m3 increment of 
PM2.5 concentration in lag 0.
Adjustment RRb (95% CI) p-Value
HRV adjusted
Log HF 1.06 (1.04–1.09) < 0.01
Log LF 1.06 (1.04–1.09) < 0.01
SDNN 1.07 (1.05–1.10) < 0.01
RMSSD 1.03 (1.00–1.05) 0.08
Not HRV adjusted 1.08 (1.05–1.10) < 0.01
aThe RRs were calculated by exponentiating the regres-
sion coefficients from distributed lag negative binomial 
regression model. bAdjusted for age, sex, race, chronic 
disease status, and the same lag period temperature and 
relative humidity.
Table 2. The cumulative RRsa (95% CIs) of ectopy counts associated with a 10-μg/m3 increment of PM2.5 
concentration.
Ectopy variable Lag RRb (95% CI)
PVC count Lag 0 (same time) 1.08 (1.05–1.10)**
Lag 0–1 (30 min before) 1.03 (1.00–1.05)*
PAC count Lag 0 (same time) 0.94 (0.85–1.04)
Lag 0–1 (30 min before) 0.97 (0.89–1.05)
Total ectopy count Lag 0 (same time) 1.05 (1.02–1.07)**
Lag 0–1 (30 min before) 1.03 (1.01–1.05)**
aThe RRs were calculated by exponentiating the regression coefficients from distributed lag negative binomial models. 
An RR of 1.05 indicates a 5% increase in ectopy count/30 min in association with a 10-µg/m3 increase in PM2.5 concen-
tration. bAdjusted for age, sex, race, chronic disease status, and the same lag period temperature and relative humidity. 
*p < 0.05. **p < 0.01.PM2.5 affects cardiac arrhythmia
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the 30-min basis of exposure, outcome, and 
covariables. This study design enabled us to 
examine the acute effect of PM2.5 exposure on 
PVC counts. Another major strength of this 
study is that we measured PM2.5 exposures, the 
ECG outcome data, and the covariables at the 
individual level on a real-time basis over 24 hr. 
With these individual-level data, we can adjust 
for individual-level time-varying and non-time-
varying confounding factors. Together with 
our findings of similar acute effects of PM2.5 
on HRV (He et al. 2010) and ventricular repo-
larization (Liao et al. 2010), our data provide 
evidence of acute effects of PM2.5 exposure 
on cardiac electrophysiological profiles. We 
found no association between PM2.5 exposures 
and PAC, consistent with the report from the 
WHI population (Liao et al. 2009). Thus, the 
association between PM2.5 exposures and the 
total ectopy counts, defined as the sum of PVC 
and PAC counts, appears to be driven by the 
association with PVC.
Mechanisms that would explain asso-
ciations between increased arrhythmia fre-
quency and PM2.5 exposure are unknown 
at this time. It is biologically plausible that 
exposures to PM2.5 directly reduce parasym-
pathetic modulation and increase sympathetic 
modulation, resulting in a decreased thresh-
old for arrhythmia. HRV is a reliable measure 
of cardiac autonomic modulation. Although 
some studies have not supported an associ-
ation between PM and HRV (Peretz et al. 
2008; Sullivan et al. 2005) and others have 
reported inverse associations (Magari et al. 
2002; Riediker et al. 2004; Wheeler et al. 
2006), most published studies have suggested 
that PM exposure is associated with lower 
HRV indices. In the present study, associa-
tions with PM2.5 were attenuated but still 
positive when we adjusted for HRV variables, 
especially RMSSD, consistent with an inter-
mediate effect of PM exposure on autonomic 
modulation. However, adjustment for HRV 
parameters did not completely eliminate asso-
ciations between PM2.5 and PVC, and other 
mechanisms might also explain associations.
In these data, the PM2.5 and PVC associa-
tion was significantly stronger among persons 
without the CVD-related chronic conditions 
(CVD, hypertension, or diabetes) than in 
persons with such conditions, who showed 
little evidence of an association. This finding 
is different from previous studies that showed 
significant adverse effects of PM2.5 on arrhyth-
mia among patients implanted with an ICD 
(Dockery et al. 2005; Peters et al. 2000; Rich 
et al. 2005). One potential explanation for this 
discrepancy is that relatively weak effects of 
PM2.5 may be difficult to detect in individuals 
at high risk of PVC from their chronic disease. 
Also, participants with CVD-related chronic 
conditions may be taking antihypertensive 
and heart rhythm control medications that 
may prevent or reduce the occurrence of PVC. 
However, the robust association between 
PM2.5 and PVC among persons without 
chronic CVD-related conditions suggests that 
PM effects on arrhythmia are not limited to 
individuals with chronic conditions.
This study has several limitations. First, 
our findings may not apply to smokers or 
persons with a recent acute cardiac event, 
because we excluded such persons from the 
study popu  lation. Second, most participants 
reported that they stayed indoors most of the 
time during the 24-hr study period, except 
when they had to travel by automobile, and 
they had limited exposure to second-hand cig-
arette smoke. Thus, participants had relatively 
low levels of exposure to PM2.5, and we cannot 
determine whether exposures at higher levels 
would result in similar associations. Third, it 
is well known that sympathetic nervous activ-
ity increases during physical activity, which 
could be related to higher PM2.5 exposure if 
it occurs outdoors and could also decrease the 
threshold of arrhythmia. However, although it 
is possible that the PM2.5 and ectopy associa-
tion in this study was confounded by physical 
activity, the vast majority of our participants 
reported staying indoors 97% of the 24-hr 
study period. Fourth, we did not collect the 
ECG data under a controlled, supine-position 
setting, and short-term variation due to other 
factors that may affect ectopy cannot be fully 
accounted for in our analysis. However, it is 
not feasible to keep a healthy participant in 
a supine indoor position for 24 hr, and even 
if this were achieved, the results from such a 
study design would not be generalizable to a 
real-world situation.
Conclusion
A 10-μg/m3 increase in PM2.5 exposure was 
associated with an immediate increase in 
arrhythmic heart beats, specifically PVC beats, 
among healthy individuals. The time course 
of the association suggested that effects were 
limited to within approximately 60 min of the 
PM2.5 exposure.
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